Ruth Ruddle - Dissemin

Language
Login

All papers authored by Ruth Ruddle

This paper was not found in any repository, but could be made available legally by the author.

2023 Christina Guo, Adam Sharp, Bora Gurel

ORCID

, Mateus Crespo

ORCID

, Ines Figueiredo, Suneil Jain, Ursula Vogl, Jan Rekowski

ORCID

, Mahtab Rouhifard, Lewis Gallagher

ORCID

, Wei Yuan, Suzanne Carreira

ORCID

, Khobe Chandran, Alec Paschalis, Ilaria Colombo

ORCID

and 34 other authors

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle

ORCID

, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, Johann de Bono, Bissan Al-Lazikani, Udai Banerji

Data from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Diana M. Carvalho, Peter J. Richardson, Nagore Olaciregui, Reda Stankunaite, Cinzia Lavarino, Valeria Molinari, Elizabeth A. Corley, Daniel P. Smith, Ruth Ruddle

ORCID

, Adam Donovan, Akos Pal, Florence I. Raynaud, Sara Temelso, Alan Mackay, John P. Overington and 15 other authors

Data from Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle

ORCID

, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, Johann de Bono, Bissan Al-Lazikani, Udai Banerji

Supplementary Table from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Diana M. Carvalho, Peter J. Richardson, Nagore Olaciregui, Reda Stankunaite, Cinzia Lavarino, Valeria Molinari, Elizabeth A. Corley, Daniel P. Smith, Ruth Ruddle

ORCID

, Adam Donovan, Akos Pal, Florence I. Raynaud, Sara Temelso, Alan Mackay, John P. Overington and 15 other authors

Supplementary Figures S1-S3 from Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle

ORCID

, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, Johann de Bono, Bissan Al-Lazikani, Udai Banerji

Supplementary Figure from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Susana Banerjee

ORCID

, Vasiliki Michalarea, Joo Ern Ang, Alvaro Ingles Garces, Andrea Biondo, Ionut-Gabriel Funingana, Martin Little, Ruth Ruddle

ORCID

, Florence Raynaud

ORCID

, Ruth Riisnaes

ORCID

, Bora Gurel, Sue Chua, Nina Tunariu, Joanna C. Porter, Toby Prout and 14 other authors

Supplementary Table from A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Susana Banerjee

ORCID

, Vasiliki Michalarea, Joo Ern Ang, Alvaro Ingles Garces, Andrea Biondo, Ionut-Gabriel Funingana, Martin Little, Ruth Ruddle

ORCID

, Florence Raynaud

ORCID

, Ruth Riisnaes

ORCID

, Bora Gurel, Sue Chua, Nina Tunariu, Joanna C. Porter, Toby Prout and 14 other authors

Data from A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Susana Banerjee

ORCID

, Vasiliki Michalarea, Joo Ern Ang, Alvaro Ingles Garces, Andrea Biondo, Ionut-Gabriel Funingana, Martin Little, Ruth Ruddle

ORCID

, Florence Raynaud

ORCID

, Ruth Riisnaes

ORCID

, Bora Gurel, Sue Chua, Nina Tunariu, Joanna C. Porter, Toby Prout and 14 other authors

Supplementary Figure from A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, Joaquin Mateo, Jessica S. Brown, Alvaro H. Ingles Garces, Ruth Ruddle

ORCID

, Shaun Decordova, Simone Jueliger, Roberta Ferraldeschi, Oscar Maiques, Victoria Sanz-Moreno, Paul Jones, Stephanie Traub, Gavin Halbert and 5 other authors

Supplementary Figure 1 from First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, Joaquin Mateo, Jessica S. Brown, Alvaro H. Ingles Garces, Ruth Ruddle

ORCID

, Shaun Decordova, Simone Jueliger, Roberta Ferraldeschi, Oscar Maiques, Victoria Sanz-Moreno, Paul Jones, Stephanie Traub, Gavin Halbert and 5 other authors

Supplementary Table 1 from First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, Joaquin Mateo, Jessica S. Brown, Alvaro H. Ingles Garces, Ruth Ruddle

ORCID

, Shaun Decordova, Simone Jueliger, Roberta Ferraldeschi, Oscar Maiques, Victoria Sanz-Moreno, Paul Jones, Stephanie Traub, Gavin Halbert and 5 other authors

Supplementary Data from First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, Joaquin Mateo, Jessica S. Brown, Alvaro H. Ingles Garces, Ruth Ruddle

ORCID

, Shaun Decordova, Simone Jueliger, Roberta Ferraldeschi, Oscar Maiques, Victoria Sanz-Moreno, Paul Jones, Stephanie Traub, Gavin Halbert and 5 other authors

Data from First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors

Upload

This paper was not found in any repository, but could be made available legally by the author.

2022 Susana Banerjee

ORCID

, Vasiliki Michalarea

ORCID

ORCID

, Alvaro Ingles Garces

ORCID

, Andrea Biondo

ORCID

, Ionut-Gabriel Funingana

ORCID

, Martin Little

ORCID

, Ruth Ruddle

ORCID

, Florence Raynaud

ORCID

, Ruth Riisnaes

ORCID

ORCID

, Sue Chua

ORCID

ORCID

, Joanna C. Porter

ORCID

ORCID

and 14 other authors

A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

Upload

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

2021 Diana M. Carvalho, Peter J. Richardson

ORCID

, Nagore Olaciregui, Reda Stankunaite

ORCID

, Cinzia Lavarino

ORCID

, Valeria Molinari, Elizabeth A. Corley

ORCID

, Daniel P. Smith, Ruth Ruddle

ORCID

, Adam Donovan, Akos Pal, Florence I. Raynaud

ORCID

ORCID

, Alan Mackay, John P. Overington

ORCID

and 15 other authors

Repurposing Vandetanib plus Everolimus for the Treatment ofACVR1-Mutant Diffuse Intrinsic Pontine Glioma

Download from aacrjournals.org

This paper is made freely available by the publisher.

Javier Pascual

ORCID

, Joline S. J. Lim

ORCID

, Iain R. Macpherson

ORCID

, Anne C. Armstrong

ORCID

, Alistair Ring, Alicia F. C. Okines

ORCID

, Rosalind J. Cutts, Maria Teresa Herrera-Abreu

ORCID

, Isaac Garcia-Murillas

ORCID

ORCID

, Sarah Hrebien, Heidrun Gevensleben, Paula Z. Proszek, Michael Hubank

ORCID

, Margaret Hills and 13 other authors

Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant inPIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers

Download from aacrjournals.org

This paper is made freely available by the publisher.

2020 Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, Joaquin Mateo, Jessica S. Brown, Alvaro H. Ingles Garces

ORCID

, Alvaro H. Ingles Garces, Ruth Ruddle

ORCID

, Shaun A. Decordova

ORCID

, Simone Jueliger, Roberta Ferraldeschi, Oscar Maiques, Victoria Sanz-Moreno

ORCID

, Paul Jones, Stephanie Traub and 6 other authors

First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors

Download from aacrjournals.org

This paper is made freely available by the publisher.

Timothy A. Yap

ORCID

, Rebecca Kristeleit

ORCID

, Vasiliki Michalarea, Stephen J. Pettitt

ORCID

, Joline S. J. Lim, Suzanne Carreira, Desamparados Roda, Rowan Miller, Ruth Riisnaes, Susana Miranda

ORCID

, Ines Figueiredo, Daniel Nava Rodrigues, Sarah Ward, Ruth Matthews

ORCID

, Mona Parmar and 21 other authors

Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non–BRCA1/2-Mutant Cancers

Download from aacrjournals.org

Missing publications? Search for publications with a matching author name.